Management of dysplastic nevi: A survey of fellows of the American Academy of Dermatology

Journal of the American Academy of Dermatology

Volumn 46, Issue 5, 2002, Pages 674-682

  Tripp, Jackie M ^a   Kopf, Alfred W ^a   Marghoob, Ashfaq A ^b,c   Bart, Robert S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

ADULT; ARTICLE; CANCER SURGERY; CLINICAL PRACTICE; DERMATOLOGY; DYSPLASTIC NEVUS; EARLY DIAGNOSIS; EPILUMINESCENCE MICROSCOPY; FOLLOW UP; HIGH RISK PATIENT; HISTOLOGY; HUMAN; MEDICAL PHOTOGRAPHY; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; MELANOMA; NORMAL HUMAN; OPHTHALMOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; RELATIVE; SELF EXAMINATION; SUN EXPOSURE;

EID: 0036587397     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.121029     Document Type: Article

References (47)

1. Clark WH, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol 1978;114: 732-8.
2. Frichot BC, Lynch HT, Guirgis HA, Harris RE, Lynch JF. New cutaneous phenotype in familial malignant melanoma. Lancet 1977; 1:864-5.
3. Lynch HT, Frichot BC, Lynch JF. Familial atypical mole-melanoma syndrome. J Med Genet 1978;15:352-6.
4. Greene MH, Clark WH, Tucker MA, Elder DE, Kraemer KH, Guerry D, et al. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med 1985;312:91-7.
5. Kelly JW, Yeatman JM, Regalia C, Mason G, Henham AP. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance. Med J Aust 1997;167: 191-4.
6. Rivers JK, Kopf AW, Vinokur AF, Rigel DS, Friedman RJ, Heilman ER, et al. Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi. Cancer 1990;65:1232-6.
7. Duray PH, Ernstoff MS. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital. Arch Dermatol 1987;123:80-4.
8. Clark WH, Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984;15: 1147-65.
9. Rhodes AR, Harrist TJ, Day CL, Mihm MC, Fitzpatrick TB, Sober AJ. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 1983;9:563-74.
10. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995;33:1000-7.
11. Slade J, Marghoob AA, Salopek TG, Rigel DS, Kopf AW, Bart RS. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol 1995;32:479-94.
12. Greene MH. The genetics of hereditary melanoma and nevi. 1998 update. Cancer 1999;86:2464-77.
13. Ackerman AB. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology 1988;13:241-56.
14. Cook MG, Fallowfield ME. Dysplastic naevi: an alternative view. Histopathology 1990;16:29-35.
15. Rigel DS, Friedman RJ, Kopf AW, Rogers GS, Heilman ER. Precursors of malignant melanoma. Problems in computing the risk of malignant melanoma arising in dysplastic and congenital nevocytic nevi. Dermatol Clin 1985;3:361-5.
16. Tucker SB, Horstmann JP, Hertel B, Aranha G, Rosai J. Activation of nevi in patients with malignant melanoma. Cancer 1980;46: 822-7.
17. Elder DE. Dysplastic nevi. Their significance and management. Dermatol Clin 1988;6:257-69.
18. Marks R, Dorevitch AP, Mason G. Do all melanomas come from "moles"? A study of the histological association between melanocytic naevi and melanoma. Australas J Dermatol 1990;31:77- 80.
19. Barnes LM, Nordlund JJ. The natural history of dysplastic nevi. A case history illustrating their evolution. Arch Dermatol 1987;123:1059-61.
20. Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001;44:837-46.
21. Barnhill RL, Hurwitz S, Duray PH, Arons MS. The dysplastic nevus: recognition and management. Plast Reconstr Surg 1988;81: 280-9.
22. Crutcher WA. The dysplastic nevus and its clinical management. Adv Dermatol 1988;3:187-203.
23. Sober AJ, Burstein JM. Precursors to skin cancer. Cancer 1995; 75:645-50.
24. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996;88:17-23.
25. Greene MH. Dysplastic nevus syndrome. Hosp Pract 1984;19:91- 108.
26. Shapiro PE. Making sense of the dysplastic nevus controversy. A unifying perspective. Am J Dermatopathol 1992;14:350-6.
27. Kelly JW, Crutcher WA, Sagebiel RW. Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation. J Am Acad Dermatol 1986;14:1044-52.
28. Cooke KR, Spears GF, Elder DE, Greene MH. Dysplastic naevi in a population-based survey. Cancer 1989;63:1240-4.
29. Piepkorn M, Meyer LJ, Goldgar D, Seuchter SA, Cannon-Albright LA, Skolnick MH, et al. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989;20:407-15.
30. Kopf AW, Rivers JK, Friedman RJ, Rigel DS, Heilman ER. Dysplastic nevi. In: Friedman FJ, Rigel DS, Kopf AW, Harris MN, Baker D, editors. Cancer of the skin. Philadelphia: Saunders; 1991. p. 125-41.
31. Rigel DS, Friedman RJ, Kopf AW. Surgical margins for removal of dysplastic nevi [abstractl. J Dermatol Surg Oncol 1985;11:745.
32. Duray PH, Livolsi VA. Recurrent dysplastic nevus following shave excision. J Dermatol Surg Oncol 1984;10:811-5.
33. NIH Consensus Conference. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-9.
34. Mihm MC. Questions to the editorial board and other authorities. Am J Dermatopathol 1985;7(Suppl):213-25.
35. Sagebiel RW. Questions to the editorial board and other authorities. Am J Dermatopathol 1985;7(Suppl):213-25.
36. Grin JM, Grant-Kels JM, Grin CM, Berke A, Kels BD. Ocular melanomas and melanocytic lesions of the eye. J Am Acad Dermatol 1998;38:716-30.
37. Kopf AW, Rivers JK, Slue W, Rigel DS, Friedman RJ. Photographs are useful for detection of malignant melanomas in patients who have dysplastic nevi. J Am Acad Dermatol 1988;19:1132-4.
38. Schosser RH, Michaels KV, Giannavola S, Morris M, Kendrick JP. Total body photographs of dysplastic nevi. Arch Dermatol 1989; 125:566-7.
39. Rapini RP. Photographs for Clark's "dysplastic" nevi? J Am Acad Dermatol 1988;19:1130-4.
40. Zemtsov A, Camisa C. Is photography necessary in following up patients with dysplastic nevi? Arch Dermatol 1989;125:563-5.
41. Coverman MH. Total-body photographs of dysplastic nevi: who pays? Arch Dermatol 1989;125:565-6.
42. Pehamberger H, Binder M, Steiner A, Wolff K. In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma. J Invest Dermatol 1993;100(Suppl):356S-362S.
43. Nachbar F, Stolz, Merkle T, Cognetta AB, Vogt T, Landthaler M, et al. The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol 1994;30:551-9.
44. Cristofolini M, Zumiani G, Bauer P, Cristofolini P, Boi S, Micciolo R. Dermatoscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. Melanoma Res 1994;4:391-4.
45. Binder M, Schwarz M, Winkler A, Steiner A, Kaider A, Wolff K, et al. Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995;131:286-91.
46. Soyer HP, Smolle J, Leitinger G, Rieger E, Kerl H. Diagnostic reliability of dermoscopic criteria for detecting malignant melanoma. Dermatology 1995;190:25-30.
47. Kreusch J, Rassner G, Trahn C, Pietsch-Breitfeld B, Henke D, Selbmann HK. Epiluminescent microscopy: a score of morphological features to identify malignant melanoma. Pigment Cell Res 1992;(Suppl 2):295-8.